137 related articles for article (PubMed ID: 7822351)
1. Cathepsin G and alpha 1-antichymotrypsin in the local host reaction to loosening of total hip prostheses.
Takagi M; Konttinen YT; Santavirta S; Kangaspunta P; Suda A; Rokkanen P
J Bone Joint Surg Am; 1995 Jan; 77(1):16-25. PubMed ID: 7822351
[TBL] [Abstract][Full Text] [Related]
2. Neutral proteinases and their inhibitors in the loosening of total hip prostheses.
Takagi M
Acta Orthop Scand Suppl; 1996 Oct; 271():3-29. PubMed ID: 8975533
[TBL] [Abstract][Full Text] [Related]
3. Tissue inhibitor of metalloproteinase 1, collagenolytic and gelatinolytic activity in loose hip endoprostheses.
Takagi M; Konttinen YT; Kemppinen P; Sorsa T; Tschesche H; Bläser J; Suda A; Santavirta S
J Rheumatol; 1995 Dec; 22(12):2285-90. PubMed ID: 8835563
[TBL] [Abstract][Full Text] [Related]
4. Elastase activity, uninhibited by alpha 1-antitrypsin, in the periprosthetic connective matrix around loose total hip prostheses.
Takagi M; Konttinen YT; Santavirta S; Kangaspunta P; Sorsa T; Yamakawa M; Suda A
J Orthop Res; 1995 Mar; 13(2):296-304. PubMed ID: 7722767
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix metalloproteinases around loose total hip prostheses.
Takagi M; Konttinen YT; Santavirta S; Sorsa T; Eisen AZ; Nordsletten L; Suda A
Acta Orthop Scand; 1994 Jun; 65(3):281-6. PubMed ID: 8042479
[TBL] [Abstract][Full Text] [Related]
6. The membrane-type-matrix metalloproteinase/matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodeling in loose total-hip prostheses.
Takagi M; Santavirta S; Ida H; Ishii M; Akimoto K; Saotome K; Konttinen YT
Lab Invest; 1998 Jun; 78(6):735-42. PubMed ID: 9645764
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of matrix proteolytic enzymes in the periprosthetic tissue in the patients with loosening prostheses.
Yang RS; Liu TK
Tohoku J Exp Med; 1998 Feb; 184(2):99-111. PubMed ID: 9605017
[TBL] [Abstract][Full Text] [Related]
8. High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints.
Takei I; Takagi M; Ida H; Ogino T; Santavirta S; Konttinen YT
J Rheumatol; 2000 Apr; 27(4):894-9. PubMed ID: 10782812
[TBL] [Abstract][Full Text] [Related]
9. Production of platelet-derived growth factor in aseptic loosening of total hip replacement.
Xu JW; Konttinen YT; Li TF; Waris V; Lassus J; Matucci-Cerinic M; Sorsa T; Santavirta TS
Rheumatol Int; 1998; 17(6):215-21. PubMed ID: 9592860
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-colony stimulating factor (M-CSF) is increased in the synovial-like membrane of the periprosthetic tissues in the aseptic loosening of total hip replacement (THR).
Xu JW; Konttinen YT; Waris V; Pätiälä H; Sorsa T; Santavirta S
Clin Rheumatol; 1997 May; 16(3):243-8. PubMed ID: 9184260
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of toll-like receptors in aseptic loose periprosthetic tissues and septic synovial membranes around total hip implants.
Tamaki Y; Takakubo Y; Goto K; Hirayama T; Sasaki K; Konttinen YT; Goodman SB; Takagi M
J Rheumatol; 2009 Mar; 36(3):598-608. PubMed ID: 19208601
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin G: the significance in rheumatoid arthritis as a monocyte chemoattractant.
Miyata J; Tani K; Sato K; Otsuka S; Urata T; Lkhagvaa B; Furukawa C; Sano N; Sone S
Rheumatol Int; 2007 Feb; 27(4):375-82. PubMed ID: 16977463
[TBL] [Abstract][Full Text] [Related]
13. Activation of periprosthetic connective tissue in aseptic loosening of total hip replacements.
Santavirta S; Xu JW; Hietanen J; Ceponis A; Sorsa T; Kontio R; Konttinen YT
Clin Orthop Relat Res; 1998 Jul; (352):16-24. PubMed ID: 9678029
[TBL] [Abstract][Full Text] [Related]
14. Presence, activities, and molecular forms of cathepsin G, elastase, alpha 1-antitrypsin, and alpha 1-antichymotrypsin in bronchiectasis.
Sepper R; Konttinen YT; Ingman T; Sorsa T
J Clin Immunol; 1995 Jan; 15(1):27-34. PubMed ID: 7759598
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha (TNF-alpha) in loosening of total hip replacement (THR).
Xu JW; Konttinen YT; Lassus J; Natah S; Ceponis A; Solovieva S; Aspenberg P; Santavirta S
Clin Exp Rheumatol; 1996; 14(6):643-8. PubMed ID: 8978959
[TBL] [Abstract][Full Text] [Related]
16. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.
Mandelin J; Li TF; Hukkanen M; Liljeström M; Salo J; Santavirta S; Konttinen YT
J Rheumatol; 2005 Apr; 32(4):713-20. PubMed ID: 15801030
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta 1 and 2 in the synovial-like interface membrane between implant and bone in loosening of total hip arthroplasty.
Konttinen YT; Waris V; Xu JW; Jiranek WA; Sorsa T; Virtanen I; Santavirta S
J Rheumatol; 1997 Apr; 24(4):694-701. PubMed ID: 9101504
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 in aseptic loosening of total hip replacement prostheses.
Konttinen YT; Xu JW; Waris E; Li TF; Gómez-Barrena E; Nordsletten L; Santavirta S
Clin Exp Rheumatol; 2002; 20(4):485-90. PubMed ID: 12175103
[TBL] [Abstract][Full Text] [Related]
19. Mast cells in loosening of totally replaced hips.
Solovieva SA; Ceponis A; Konttinen YT; Takagi M; Suda A; Eklund KK; Sorsa T; Santavirta S
Clin Orthop Relat Res; 1996 Jan; (322):158-65. PubMed ID: 8542692
[TBL] [Abstract][Full Text] [Related]
20. Basic fibroblast growth factor (bFGF) in the synovial-like membrane around loose total hip prostheses.
Waris V; Xu JW; Nordsletten L; Sorsa T; Santavirta S; Konttinen YT
Scand J Rheumatol; 1996; 25(4):257-62. PubMed ID: 8792803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
